This archive contains all documents published by cep over the last few years:
cepAdhoc: Incisive comment on current EU policy issues.
cepPolicyBrief: Concise 4-page reviews of EU proposals (Regulations, Directives, Green Papers, White Papers, Communications) – including a brief summary and economic and legal assessments.
cepInput: Impulse to current discussions of EU policies.
cepStudy: Comprehensive examination of EU policy proposals affecting the economy.
In view of increasing EU-wide violations, the EU-Commission wants to strengthen the enforcement of, and thus improve compliance with, EU consumer protection law. In the context of its “New Deal for Consumers”, it has submitted a corresponding Directive.
By way of an exemption from protection certificates, the EU wants to permit the manufacture of generics and so-called biosimilars for export, even where the original medicine is still protected by a certificate in the EU. Using this exemption, it wants to remedy competitive disadvantages for EU manufacturers and strengthen its generics and biosimilars industry.
A new EU Directive on representative actions for the protection of the collective interests of consumers is to replace the existing Directive on injunctive relief. It is supposed to substantially expand the scope of representative actions in consumer law and thereby to promote the enforcement of consumer law whilst at the same time preventing abusive litigation.
The EU Commission wants to create joint clinical assessments and harmonised assessment procedures at EU level for innovative health technology in order to remove barriers in the internal market. Thus, redundant duplication of work both in national HTA centres and for developers of health technology can be avoided and costs, currently incurred by developers due to differing national assessment concepts, can be reduced.
Due to reasons of cost, traders refrain from offering their goods across borders and consumers shy away from purchasing in other countries due to legal uncertainty. The Commission wants to change this by way of a Directive. It wants to remove barriers in cross-border trade with extensive full-harmonisation of guarantee law for sales of goods.
The EU Commission wants to increase efforts to combat the spread of antimicrobial resistance. With this aim, it has submitted a European Action Plan in line with the concept of “One Health”. In cep’s view, this is a sensible European initiative because resistant pathogens spread across borders thus making it necessary to take both EU-wide and global combating measures.
The EU Commission wants to make the transmission of personal data to non-EU countries easier in order to promote mutual trade and effectively combat international crime.